Resources

List by Alphabet: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

immunogenicity

Immunogenicity refers to the ability of a substance, typically a foreign protein or a biological therapeutic agent, to provoke an immune response in the body. This concept is particularly significant in the development and use of biologic drugs, such as monoclonal antibodies, vaccines, and gene therapies. Understanding and managing immunogenicity is crucial because an immune response can affect the safety and efficacy of these therapies. Key aspects of immunogenicity include:

1. Immune Response to Therapeutics: Biologic therapeutics can be recognized as foreign by the patient’s immune system, leading to the production of anti-drug antibodies (ADAs). These ADAs can neutralize the therapeutic agent, reducing its efficacy, or lead to adverse immune reactions.

2. Factors Influencing Immunogenicity: Various factors can affect the immunogenicity of a therapeutic agent, including the drug’s molecular structure, dosage, route of administration, treatment duration, and the patient's own immune system and genetic background.

3. Clinical Implications: The development of an immune response against a therapeutic agent can lead to reduced drug effectiveness, hypersensitivity reactions, autoimmunity, or other adverse effects. In some cases, it can also lead to the neutralization of endogenous proteins if they are similar to the therapeutic agent.

4. Testing and Assessment: Immunogenicity is routinely assessed in the preclinical and clinical development of biologic drugs. This involves detecting and characterizing ADAs and evaluating their impact on drug safety and efficacy.

5. Vaccines: In the context of vaccines, immunogenicity is desirable and is a measure of the vaccine's effectiveness in inducing an immune response that will protect against the target disease.

6. Protein Engineering: To reduce immunogenicity, therapeutic proteins may be engineered to more closely resemble human proteins, thereby reducing their foreignness to the immune system. Techniques include humanization of monoclonal antibodies or using recombinant human proteins.

7. Tolerance Induction: Strategies to induce immune tolerance to the therapeutic agent are an area of active research. This includes methods to modulate the immune response or to deliver the drug in a way that reduces its immunogenic potential.

8. Regulatory Considerations: Regulatory agencies require comprehensive immunogenicity testing for the approval of biologic therapeutics. Developers must demonstrate that they have evaluated and mitigated potential immunogenic risks.

9. Monitoring in Clinical Use: Post-market surveillance is important to monitor for immunogenicity, as some immune responses may only become apparent after a drug has been widely used in a diverse patient population.

Immunogenicity is a double-edged sword in biomedicine. While it is the foundation of effective vaccines, it presents a significant challenge in the development and use of therapeutic biologics, where an unwanted immune response can compromise treatment efficacy and patient safety.

Related Biology Tools

  • GenSmart™ Codon Optimization

    GenSmart Optimization is a free online tool for performing codon optimization to improve gene expression. GenScript's patented algorithms are integrated into the tool to optimize the computing capability of high-performance sequence generation.

    Learn More

  • DNA Construct Design Tool

    GenSmart™ Design is a free online DNA construct design tool developed by GenScript. GenSmart™ Design has two design modules, the Create Construct module for individual plasmid design and the Create Library module for DNA library design.

    Learn More

  • Codon Frequency Tables

    This online tool shows commonly used genetic codon frequency table in expression host organisms including Escherichia coli and other common host organisms.

    Learn More

Service and Products

Antibody Production Services

Comprehensive custom antibody production services including monoclonal and polyclonal antibody production services with industry leading turnaround times.

Polyclonal Antibody Services

The fastest custom polyclonal antibody production services in the industry with unmatched guarantees.

Custom Monoclonal Antibody Development Services

Developing custom monoclonal antibodies with standard or fully custom protocols including everything from antigen synthesis to antibody scale-up options.

Phospho-Specific Antibody Services

Guaranteed ELISA titer of ≥ 1:64,000 and < 10% cross reactivity with non-phospho peptide.

Immunoassay Development Services

Our custom immunoassay development service offering comprehensive high-throughput assay development with fast turnaround and high efficiency.

Large-scale Antibody Manufacturing

Our large-scale antibody manufacturing services offer polyclonal and monoclonal antibody production of gram quantities for industrial antibody yields.

COVID-19 Reagent Antibodies

On demand SARS-CoV-2 control mAbs ideal for diagnostics, therapeutic, and vaccine development.

If you know of any terms that have been omitted from this glossary that you feel would be useful to include, please send detail to the Editorial Office at GenScript: [email protected]

If your term is adopted, we will send 1,000 EzCoupon points to your GenScript account.